default author photo

Pari V. Pandharipande

affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

35

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Survival Benefit of Universal Homologous Recombination Deficiency Testing in Ovarian Cancer Patients

Number of pages: 23 Posted: 16 Jun 2026
Stanford University, affiliation not provided to SSRN, affiliation not provided to SSRN, Tufts University - Tufts Medical Center, Columbia University College of Physicians and Surgeons, Columbia University College of Physicians and Surgeons, Harvard University - Dana-Farber Cancer Institute, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital, Tufts University - Tufts Medical Center and affiliation not provided to SSRN
Downloads 18

Abstract:

Loading...

decision analysis, advanced ovarian cancer, homologous recombination deficient tumors, poly(ADP-ribose) polymerase inhibitors

2.

The impact of comorbidity and guideline-concordant care on survival in ovarian cancer patients

Number of pages: 24 Posted: 14 Jan 2026
Columbia University College of Physicians and Surgeons, Columbia University College of Physicians and Surgeons, Columbia University College of Physicians and Surgeons, Columbia University College of Physicians and Surgeons, Stanford University, affiliation not provided to SSRN, affiliation not provided to SSRN, Harvard University - Dana-Farber Cancer Institute, affiliation not provided to SSRN, Harvard University - Massachusetts General Hospital, affiliation not provided to SSRN and Columbia University - Irving Medical Center
Downloads 17 (1,509,872)

Abstract:

Loading...

Comorbidity, Treatment, guidelines, ovarian cancer, interaction